• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

India's syndemic of tuberculosis and COVID-19.

作者信息

Shrinivasan Rukmini, Rane Saurabh, Pai Madhukar

机构信息

Independent Data Journalist, Chennai, India.

Survivors Against Tuberculosis, Mumbai, India.

出版信息

BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-003979.

DOI:10.1136/bmjgh-2020-003979
PMID:33199280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7670552/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/423baf4c70c4/bmjgh-2020-003979f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/778573fa01b0/bmjgh-2020-003979f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/dd19c6427bf3/bmjgh-2020-003979f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/1d755167df21/bmjgh-2020-003979f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/423baf4c70c4/bmjgh-2020-003979f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/778573fa01b0/bmjgh-2020-003979f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/dd19c6427bf3/bmjgh-2020-003979f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/1d755167df21/bmjgh-2020-003979f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e1e/7670552/423baf4c70c4/bmjgh-2020-003979f04.jpg

相似文献

1
India's syndemic of tuberculosis and COVID-19.印度的结核病与新冠疫情并发情况。
BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-003979.
2
The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic.新型冠状病毒肺炎/结核病综合征及从大流行中吸取的经验教训对结核病抗体治疗的启示
Front Immunol. 2022 Feb 15;13:833715. doi: 10.3389/fimmu.2022.833715. eCollection 2022.
3
Tuberculosis patients not covered by treatment in public health services: findings from India's National Family Health Survey 2015-16.未在公共卫生服务中接受治疗的结核病患者：来自印度 2015-16 年国家家庭健康调查的发现。
Trop Med Int Health. 2018 Aug;23(8):886-895. doi: 10.1111/tmi.13086. Epub 2018 Jun 25.
4
EXPERIENCING SYNDEMIC: DISENTANGLING THE BIOSOCIAL COMPLEXITY OF TUBERCULOSIS THROUGH QUALITATIVE RESEARCH.体验综合征：通过定性研究剖析结核病的生物社会复杂性
J Biosoc Sci. 2019 May;51(3):403-417. doi: 10.1017/S0021932018000263. Epub 2018 Oct 9.
5
Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?终结结核病合并流行：新冠疫情是否成为进展不佳的（不）便利替罪羊？
Lancet Respir Med. 2022 Jun;10(6):529-531. doi: 10.1016/S2213-2600(22)00123-0. Epub 2022 Mar 23.
6
India's pain: beyond COVID-19 case numbers and mortality rates.印度之痛：超越新冠病例数和死亡率
Lancet. 2021 Jun 26;397(10293):2463. doi: 10.1016/S0140-6736(21)01248-4.
7
Dismal global tuberculosis situation due to COVID-19.由于新冠疫情导致全球结核病形势严峻。
Lancet Infect Dis. 2021 Dec;21(12):1636. doi: 10.1016/S1473-3099(21)00713-1.
8
COVID-19 and syndemic challenges in 'Battling the Big Three': HIV, TB and malaria.COVID-19 与“三大会战”中的流行疾病挑战：艾滋病毒、结核病和疟疾。
Int J Infect Dis. 2021 May;106:29-32. doi: 10.1016/j.ijid.2021.03.071. Epub 2021 Mar 26.
9
Tuberculosis management in India during COVID-19 crisis.印度在新冠疫情期间的结核病管理。
J Public Health Policy. 2021 Mar;42(1):185-189. doi: 10.1057/s41271-020-00265-8. Epub 2020 Nov 24.
10
India's private sector needs to take greater role in tuberculosis care.印度私营部门需要在结核病护理中发挥更大作用。
BMJ. 2016 Sep 2;354:i4774. doi: 10.1136/bmj.i4774.

引用本文的文献

1
Impact of the COVID-19 Pandemic on Tuberculosis: A Retrospective Analytical Study of Morbidity Profiles, Trends, and Patient Care in a Primary Tuberculosis Treatment Unit in India.新冠疫情对结核病的影响：印度一家初级结核病治疗单位发病率情况、趋势及患者护理的回顾性分析研究
Cureus. 2025 Apr 9;17(4):e81939. doi: 10.7759/cureus.81939. eCollection 2025 Apr.
2
Impact of the COVID-19 pandemic on the epidemiology and clinical course of tuberculosis: expected and paradoxical consequences.2019年冠状病毒病大流行对结核病流行病学和临床病程的影响：预期及矛盾的后果
BMC Infect Dis. 2025 Mar 26;25(1):417. doi: 10.1186/s12879-025-10793-x.
3

本文引用的文献

1
The potential impact of the COVID-19 response related lockdown on TB incidence and mortality in India.与应对新冠疫情相关的封锁措施对印度结核病发病率和死亡率的潜在影响。
Indian J Tuberc. 2020 Dec;67(4S):S139-S146. doi: 10.1016/j.ijtb.2020.07.004. Epub 2020 Jul 10.
2
Social determinants of tuberculosis: context, framework, and the way forward to ending TB in India.结核病的社会决定因素：背景、框架和印度终结结核病的前进道路。
Expert Rev Respir Med. 2021 Jul;15(7):867-883. doi: 10.1080/17476348.2021.1832469. Epub 2020 Oct 20.
3
Understanding why at-risk population segments do not seek care for tuberculosis: a precision public health approach in South India.
The long-term impact of the COVID-19 pandemic on tuberculosis care and infection control measures in anti-retroviral therapy (ART) clinics in low- and middle-income countries: a multiregional site survey in Asia and Africa.
2019年冠状病毒病大流行对低收入和中等收入国家抗逆转录病毒治疗（ART）诊所结核病护理和感染控制措施的长期影响：一项在亚洲和非洲的多地区实地调查
BMJ Glob Health. 2025 Mar 24;10(3):e017828. doi: 10.1136/bmjgh-2024-017828.
4
Impact of COVID-19 pandemic on tuberculosis notification and outcome in a district of South Gujarat.新冠疫情对古吉拉特邦南部某地区结核病报告及转归的影响
J Family Med Prim Care. 2024 Nov;13(11):4861-4865. doi: 10.4103/jfmpc.jfmpc_428_24. Epub 2024 Nov 18.
5
Case fatality among people with drug-susceptible TB enrolled in a private health sector TB treatment support program in Bihar, India during the first year of the COVID-19 pandemic.在印度比哈尔邦一个私营卫生部门结核病治疗支持项目中登记的药物敏感型结核病患者在2019年冠状病毒病大流行第一年的病死率。
PLOS Glob Public Health. 2024 Sep 12;4(9):e0003277. doi: 10.1371/journal.pgph.0003277. eCollection 2024.
6
Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.评估新冠疫情管理对印度国家消除结核病计划中人力资源工作量的影响。
BMC Health Serv Res. 2024 Aug 7;24(1):907. doi: 10.1186/s12913-024-11131-8.
7
The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020-2023.2020 - 2023年新冠疫情对结核病的全球影响：一项主题范围综述
PLOS Glob Public Health. 2024 Jul 3;4(7):e0003043. doi: 10.1371/journal.pgph.0003043. eCollection 2024.
8
A Descriptive Study on the Clinical Profile and Outcomes of Patients with COVID-19 and Tuberculosis Co-infection.新型冠状病毒肺炎与结核病合并感染患者的临床特征及预后的描述性研究
Acta Med Philipp. 2024 May 15;58(8):42-49. doi: 10.47895/amp.vi0.7855. eCollection 2024.
9
Is Pollution the Primary Driver of Infectious Syndemics?污染是传染性综合征的主要驱动因素吗？
Pathogens. 2024 Apr 30;13(5):370. doi: 10.3390/pathogens13050370.
10
Triple Burden: The Incorrigible Threat of Tuberculosis, HIV, and COVID-19.三重负担：结核病、艾滋病病毒和 COVID-19 的不治之症威胁。
Infect Disord Drug Targets. 2024;24(4):1-7. doi: 10.2174/0118715265259959231031104820.
了解为何高危人群不寻求结核病治疗：印度南部的精准公共卫生方法。
BMJ Glob Health. 2020 Sep;5(9). doi: 10.1136/bmjgh-2020-002555.
4
Covid-19 exposes the high cost of India's reliance on private healthcare.新冠疫情暴露了印度依赖私立医疗保健的高昂代价。
BMJ. 2020 Sep 10;370:m3506. doi: 10.1136/bmj.m3506.
5
Is India missing COVID-19 deaths?印度是否遗漏了新冠死亡病例？
Lancet. 2020 Sep 5;396(10252):657. doi: 10.1016/S0140-6736(20)31857-2.
6
Quality of tuberculosis care in the private health sector.私营卫生部门的结核病护理质量。
J Clin Tuberc Other Mycobact Dis. 2020 Jun 13;20:100171. doi: 10.1016/j.jctube.2020.100171. eCollection 2020 Aug.
7
Missing men with tuberculosis: the need to address structural influences and implement targeted and multidimensional interventions.男性结核病患者缺失：需要解决结构性影响，实施有针对性和多维度的干预措施。
BMJ Glob Health. 2020 May;5(5). doi: 10.1136/bmjgh-2019-002255.
8
Tuberculosis case fatality in India: a systematic review and meta-analysis.印度的结核病病死率：系统评价和荟萃分析。
BMJ Glob Health. 2020 Jan 20;5(1):e002080. doi: 10.1136/bmjgh-2019-002080. eCollection 2020.
9
Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.用于结核病治疗管理的数字依从性技术：描绘现状与研究重点
BMJ Glob Health. 2018 Oct 11;3(5):e001018. doi: 10.1136/bmjgh-2018-001018. eCollection 2018.
10
Variations in the quality of tuberculosis care in urban India: A cross-sectional, standardized patient study in two cities.印度城市结核病护理质量的差异：两个城市的横断面标准化患者研究。
PLoS Med. 2018 Sep 25;15(9):e1002653. doi: 10.1371/journal.pmed.1002653. eCollection 2018 Sep.